Clinical Trials Search

Titlesort descending Intervention NCT ID Sponsor Status
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 International Breast Cancer Study Group Active, not recruiting
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation Pamidronate, Calcium and vitamin D NCT02074631 Masonic Cancer Center, University of Minnesota Recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Recruiting
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Rilimogene Galvacirepvec, Placebo Administration NCT02326805 National Cancer Institute (NCI) Active, not recruiting
Radiation Therapy in Treating Patients With Prostate Cancer 36.25 Gy IMRT, 51.6 Gy IMRT NCT01434290 Radiation Therapy Oncology Group Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting
Relaxation for Women With Breast Cancer Undergoing Radiotherapy Relaxation Program, Questionnaires, Saliva Testing NCT01202851 M.D. Anderson Cancer Center Active, not recruiting
Reproductive Health Program in Patients With Cancer educational intervention, questionnaire administration, quality-of-life assessment NCT01806129 Eastern Cooperative Oncology Group Recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Retinoid 9cUAB30, Therapeutic Conventional Surgery NCT02876640 National Cancer Institute (NCI) Recruiting
S0820, Adenoma and Second Primary Prevention Trial Eflornithine placebo & sulindac placebo, eflornithine & sulindac placebo, Eflornithine placebo & sulindac, Eflornithine plus sulindac NCT01349881 Southwest Oncology Group Recruiting

Pages